Leukocyte-Associated Ig-Like Receptor 1 Human Recombinant, LAIR1 Human, 20ug
Leukocyte-Associated Ig-Like Receptor 1 Human Recombinant, LAIR1 Human, 20ug
| CAT No.BT-PRO-431 | 
| Leukocyte-Associated Ig-Like Receptor 1 Human Recombinant, LAIR1 Human, 20ug | 
Description
LAIR1 Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing amino acids 105 and having a molecular mass of 11.5 kDa. The extracellular domain of LAIR-1 (22-125aa) was overexpressed in E.coli, and purified by using conventional chromatography techniques.
Formulation
The protein (1mg/ml) contains 20mM Tris-HCl (pH7.5) 50mM NaCl and 1mM EDTA.
Physical Appearance
Sterile filtered colorless solution.
(b) Analysis by SDS-PAGE.
Sequence
MQEEDLPRPS ISAEPGTVIP LGSHVTFVCR GPVGVQTFRL ERESRSTYND TEDVSQASPSESEARFRIDS VSEGNAGPYR CIYYKPPKWS EQSDYLELLV KETSG.
Source
Escherichia Coli.
Stability
Store at 4¡ãC if entire vial will be used within 2-4 weeks.
Store, frozen at -20¡ãC for longer periods of time. 
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Avoid multiple freeze-thaw cycles.
Synonyms
Leukocyte-associated immunoglobulin-like receptor 1, LAIR-1, hLAIR1, CD305 antigen, LAIR1, CD305.
Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
                      
                        
                        
                          Product features
                        
                      
                    Product features
                      
                        
                        
                          Materials and care
                        
                      
                    Materials and care
                      
                        
                        
                          Merchandising tips
                        
                      
                    Merchandising tips
Share
 
 

 
               
     
    